Lantern Pharma Inc.
NASDAQ:LTRN

Watchlist Manager
Lantern Pharma Inc. Logo
Lantern Pharma Inc.
NASDAQ:LTRN
Watchlist
Price: 3.5101 USD -0.56% Market Closed
Market Cap: 37.8m USD
Have any thoughts about
Lantern Pharma Inc.?
Write Note

Lantern Pharma Inc.
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lantern Pharma Inc.
Net Income (Common) Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Lantern Pharma Inc.
NASDAQ:LTRN
Net Income (Common)
-$16m
CAGR 3-Years
-39%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income (Common)
$5.1B
CAGR 3-Years
-12%
CAGR 5-Years
9%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Net Income (Common)
$126m
CAGR 3-Years
-74%
CAGR 5-Years
-46%
CAGR 10-Years
-35%
Amgen Inc
NASDAQ:AMGN
Net Income (Common)
$4.2B
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income (Common)
-$479.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income (Common)
$4.7B
CAGR 3-Years
-13%
CAGR 5-Years
17%
CAGR 10-Years
30%

See Also

What is Lantern Pharma Inc.'s Net Income (Common)?
Net Income (Common)
-16m USD

Based on the financial report for Dec 31, 2023, Lantern Pharma Inc.'s Net Income (Common) amounts to -16m USD.

What is Lantern Pharma Inc.'s Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-56%

Over the last year, the Net Income (Common) growth was -12%. The average annual Net Income (Common) growth rates for Lantern Pharma Inc. have been -39% over the past three years , -56% over the past five years .

Back to Top